Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine in adults in Portugal versus "no vaccination" and versus vaccination with the 23-valent pneumococcal polysaccharide vaccine.
Hum Vaccin Immunother
; 15(4): 850-858, 2019.
Article
in En
| MEDLINE
| ID: mdl-30633615
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pneumococcal Infections
/
Vaccination
/
Cost-Benefit Analysis
/
Pneumococcal Vaccines
Type of study:
Health_economic_evaluation
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Humans
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Hum Vaccin Immunother
Year:
2019
Type:
Article
Affiliation country:
Portugal